| Bioactivity | Aladorian (ARM036) sodium is a benzothiazepine derivative, with anti-arrhythmia effect. Aladorian sodium is a ryanodine receptor (RyR2) blocker. Aladorian sodium is used for the research of heart failure and catecholaminergic polymorphic ventricular tachycardia[1][2][3]. |
| CAS | 1233219-11-8 |
| Formula | C12H12NNaO4S |
| Molar Mass | 289.28 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Thevis M, et al. Analytical approaches for the detection of emerging therapeutics and non-approved drugs in human doping controls. J Pharm Biomed Anal. 2014 Dec;101:66-83. [2]. Luo M, et al. Mechanisms of altered Ca²⁺ handling in heart failure. Circ Res. 2013 Aug 30;113(6):690-708. [3]. Kupatt C, et al. Ryanodine Receptors Matter for Cardiac Function in Duchenne Muscular Dystrophy: Stability First. J Am Coll Cardiol. 2021 Dec 14;78(24):2454-2456. |
Aladorian sodium
CAS: 1233219-11-8 F: C12H12NNaO4S W: 289.28
Aladorian (ARM036) sodium is a benzothiazepine derivative, with anti-arrhythmia effect.Aladorian sodium is a ryanodine r
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.